(BVI) Bureau Veritas - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0006174348
Testing, Inspection, Certification, Auditing, Compliance
Description: BVI Bureau Veritas October 31, 2025
Bureau Veritas SA (ticker BVI) is a French-based provider of laboratory testing, inspection, and certification services, operating in roughly 140 countries through a network of offices and laboratories.
The firm is organized into six segments-Marine & Offshore; Agri-Food & Commodities; Industry; Buildings & Infrastructure; Certification; and Consumer Products-delivering technical inspections, audits, compliance reporting, and certification of products, assets, and management systems across sectors such as construction, oil & gas, aerospace, automotive, utilities, and public services.
Key performance indicators from the most recent fiscal year (FY 2023) show revenue of approximately €5.7 billion, an operating margin near 12 %, and organic growth of about 4 % driven largely by higher demand for ESG-related certification and infrastructure-project support.
Economic drivers that materially affect Bureau Veritas include global infrastructure spending (projected to exceed $15 trillion through 2027), tightening environmental and safety regulations, and the acceleration of supply-chain risk management-all of which boost demand for third-party verification and testing services.
For a deeper quantitative assessment, you may find the ValueRay platform’s detailed valuation metrics and scenario analyses useful.
BVI Stock Overview
| Market Cap in USD | 14,711m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception | 2007-10-24 |
BVI Stock Ratings
| Growth Rating | 15.5% |
| Fundamental | 84.4% |
| Dividend Rating | 71.2% |
| Return 12m vs S&P 500 | -12.6% |
| Analyst Rating | - |
BVI Dividends
| Dividend Yield 12m | 3.23% |
| Yield on Cost 5y | 4.89% |
| Annual Growth 5y | 32.11% |
| Payout Consistency | 88.6% |
| Payout Ratio | 62.1% |
BVI Growth Ratios
| Growth Correlation 3m | 67.5% |
| Growth Correlation 12m | -40.6% |
| Growth Correlation 5y | 68.9% |
| CAGR 5y | 6.43% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.31 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.98 |
| Sharpe Ratio 12m | 0.72 |
| Alpha | -12.73 |
| Beta | 0.705 |
| Volatility | 18.02% |
| Current Volume | 915.6k |
| Average Volume 20d | 705.7k |
| Stop Loss | 27 (-3.2%) |
| Signal | 1.09 |
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (1.16b TTM) > 0 and > 6% of Revenue (6% = 749.5m TTM) |
| FCFTA 0.23 (>2.0%) and ΔFCFTA 11.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.48% (prev 12.85%; Δ -9.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.28 (>3.0%) and CFO 1.82b > Net Income 1.16b (YES >=105%, WARN >=100%) |
| Net Debt (1.72b) to EBITDA (2.48b) ratio: 0.69 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (451.5m) change vs 12m ago -1.12% (target <= -2.0% for YES) |
| Gross Margin 48.41% (prev 32.59%; Δ 15.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 182.4% (prev 120.3%; Δ 62.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.22 (EBITDA TTM 2.48b / Interest Expense TTM 207.2m) >= 6 (WARN >= 3) |
Altman Z'' 3.54
| (A) 0.07 = (Total Current Assets 2.92b - Total Current Liabilities 2.48b) / Total Assets 6.56b |
| (B) 0.21 = Retained Earnings (Balance) 1.39b / Total Assets 6.56b |
| (C) 0.28 = EBIT TTM 1.91b / Avg Total Assets 6.85b |
| (D) 0.52 = Book Value of Equity 2.62b / Total Liabilities 5.08b |
| Total Rating: 3.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.41
| 1. Piotroski 8.50pt = 3.50 |
| 2. FCF Yield 10.57% = 5.0 |
| 3. FCF Margin 12.27% = 3.07 |
| 4. Debt/Equity 1.79 = 1.07 |
| 5. Debt/Ebitda 0.69 = 2.14 |
| 6. ROIC - WACC (= 27.36)% = 12.50 |
| 7. RoE 66.64% = 2.50 |
| 8. Rev. Trend 51.97% = 3.90 |
| 9. EPS Trend 14.69% = 0.73 |
What is the price of BVI shares?
As of November 09, 2025, the stock is trading at EUR 27.88 with a total of 915,595 shares traded.
Over the past week, the price has changed by -2.11%, over one month by +3.03%, over three months by +3.49% and over the past year by -0.30%.
Over the past week, the price has changed by -2.11%, over one month by +3.03%, over three months by +3.49% and over the past year by -0.30%.
Is Bureau Veritas a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, Bureau Veritas (PA:BVI) is currently (November 2025)
a good stock to buy. It has a ValueRay Fundamental Rating of 84.41 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BVI is around 27.25 EUR . This means that BVI is currently overvalued and has a potential downside of -2.26%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BVI is around 27.25 EUR . This means that BVI is currently overvalued and has a potential downside of -2.26%.
Is BVI a buy, sell or hold?
Bureau Veritas has no consensus analysts rating.
What are the forecasts/targets for the BVI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.8 | 21.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30.1 | 7.9% |
BVI Fundamental Data Overview January 01, 1970
Market Cap USD = 14.71b (12.78b EUR * 1.1507 EUR.USD)
Market Cap EUR = 12.78b (12.78b EUR * 1.0 EUR.EUR)
P/E Trailing = 19.8759
P/E Forward = 17.3913
P/S = 1.9306
P/B = 8.3986
P/EG = 2.2583
Beta = 0.705
Revenue TTM = 12.49b EUR
EBIT TTM = 1.91b EUR
EBITDA TTM = 2.48b EUR
Long Term Debt = 1.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 341.4m EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b EUR (from netDebt column, last quarter)
Enterprise Value = 14.50b EUR (12.78b + Debt 2.58b - CCE 867.5m)
Interest Coverage Ratio = 9.22 (Ebit TTM 1.91b / Interest Expense TTM 207.2m)
FCF Yield = 10.57% (FCF TTM 1.53b / Enterprise Value 14.50b)
FCF Margin = 12.27% (FCF TTM 1.53b / Revenue TTM 12.49b)
Net Margin = 9.31% (Net Income TTM 1.16b / Revenue TTM 12.49b)
Gross Margin = 48.41% ((Revenue TTM 12.49b - Cost of Revenue TTM 6.44b) / Revenue TTM)
Gross Margin QoQ = 23.27% (prev 100.0%)
Tobins Q-Ratio = 2.21 (Enterprise Value 14.50b / Total Assets 6.56b)
Interest Expense / Debt = 1.58% (Interest Expense 40.8m / Debt 2.58b)
Taxrate = 26.06% (119.0m / 456.7m)
NOPAT = 1.41b (EBIT 1.91b * (1 - 26.06%))
Current Ratio = 1.18 (Total Current Assets 2.92b / Total Current Liabilities 2.48b)
Debt / Equity = 1.79 (Debt 2.58b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 0.69 (Net Debt 1.72b / EBITDA 2.48b)
Debt / FCF = 1.12 (Net Debt 1.72b / FCF TTM 1.53b)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.73% (Net Income 1.16b / Total Assets 6.56b)
RoE = 66.64% (Net Income TTM 1.16b / Total Stockholder Equity 1.74b)
RoCE = 52.52% (EBIT 1.91b / Capital Employed (Equity 1.74b + L.T.Debt 1.89b))
RoIC = 34.72% (NOPAT 1.41b / Invested Capital 4.07b)
WACC = 7.36% (E(12.78b)/V(15.37b) * Re(8.61%) + D(2.58b)/V(15.37b) * Rd(1.58%) * (1-Tc(0.26)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.72%
[DCF Debug] Terminal Value 79.62% ; FCFE base≈1.26b ; Y1≈1.55b ; Y5≈2.64b
Fair Price DCF = 90.94 (DCF Value 40.34b / Shares Outstanding 443.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 14.69 | EPS CAGR: 122.7% | SUE: -0.12 | # QB: 0
Revenue Correlation: 51.97 | Revenue CAGR: 9.19% | SUE: 0.03 | # QB: 0
Market Cap EUR = 12.78b (12.78b EUR * 1.0 EUR.EUR)
P/E Trailing = 19.8759
P/E Forward = 17.3913
P/S = 1.9306
P/B = 8.3986
P/EG = 2.2583
Beta = 0.705
Revenue TTM = 12.49b EUR
EBIT TTM = 1.91b EUR
EBITDA TTM = 2.48b EUR
Long Term Debt = 1.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 341.4m EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b EUR (from netDebt column, last quarter)
Enterprise Value = 14.50b EUR (12.78b + Debt 2.58b - CCE 867.5m)
Interest Coverage Ratio = 9.22 (Ebit TTM 1.91b / Interest Expense TTM 207.2m)
FCF Yield = 10.57% (FCF TTM 1.53b / Enterprise Value 14.50b)
FCF Margin = 12.27% (FCF TTM 1.53b / Revenue TTM 12.49b)
Net Margin = 9.31% (Net Income TTM 1.16b / Revenue TTM 12.49b)
Gross Margin = 48.41% ((Revenue TTM 12.49b - Cost of Revenue TTM 6.44b) / Revenue TTM)
Gross Margin QoQ = 23.27% (prev 100.0%)
Tobins Q-Ratio = 2.21 (Enterprise Value 14.50b / Total Assets 6.56b)
Interest Expense / Debt = 1.58% (Interest Expense 40.8m / Debt 2.58b)
Taxrate = 26.06% (119.0m / 456.7m)
NOPAT = 1.41b (EBIT 1.91b * (1 - 26.06%))
Current Ratio = 1.18 (Total Current Assets 2.92b / Total Current Liabilities 2.48b)
Debt / Equity = 1.79 (Debt 2.58b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 0.69 (Net Debt 1.72b / EBITDA 2.48b)
Debt / FCF = 1.12 (Net Debt 1.72b / FCF TTM 1.53b)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.73% (Net Income 1.16b / Total Assets 6.56b)
RoE = 66.64% (Net Income TTM 1.16b / Total Stockholder Equity 1.74b)
RoCE = 52.52% (EBIT 1.91b / Capital Employed (Equity 1.74b + L.T.Debt 1.89b))
RoIC = 34.72% (NOPAT 1.41b / Invested Capital 4.07b)
WACC = 7.36% (E(12.78b)/V(15.37b) * Re(8.61%) + D(2.58b)/V(15.37b) * Rd(1.58%) * (1-Tc(0.26)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.72%
[DCF Debug] Terminal Value 79.62% ; FCFE base≈1.26b ; Y1≈1.55b ; Y5≈2.64b
Fair Price DCF = 90.94 (DCF Value 40.34b / Shares Outstanding 443.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 14.69 | EPS CAGR: 122.7% | SUE: -0.12 | # QB: 0
Revenue Correlation: 51.97 | Revenue CAGR: 9.19% | SUE: 0.03 | # QB: 0